Article Versions Notes

Frolova SG, Vatlin AA, Maslov DA, Yusuf B, Buravchenko GI, Bekker OB, Klimina KM, Smirnova SV, Shnakhova LM, Malyants IK, et al. Novel Derivatives of Quinoxaline-2-carboxylic Acid 1,4-Dioxides as Antimycobacterial Agents: Mechanistic Studies and Therapeutic Potential. Pharmaceuticals. 2023; 16(11):1565. https://doi.org/10.3390/ph16111565

Frolova, Svetlana G., Aleksey A. Vatlin, Dmitry A. Maslov, Buhari Yusuf, Galina I. Buravchenko, Olga B. Bekker, Ksenia M. Klimina, Svetlana V. Smirnova, Lidia M. Shnakhova, Irina K. Malyants, and et al. 2023. "Novel Derivatives of Quinoxaline-2-carboxylic Acid 1,4-Dioxides as Antimycobacterial Agents: Mechanistic Studies and Therapeutic Potential" Pharmaceuticals 16, no. 11: 1565. https://doi.org/10.3390/ph16111565

Frolova, S. G., Vatlin, A. A., Maslov, D. A., Yusuf, B., Buravchenko, G. I., Bekker, O. B., Klimina, K. M., Smirnova, S. V., Shnakhova, L. M., Malyants, I. K., Lashkin, A. I., Tian, X., Alam, M. S., Zatonsky, G. V., Zhang, T., Shchekotikhin, A. E., & Danilenko, V. N. (2023). Novel Derivatives of Quinoxaline-2-carboxylic Acid 1,4-Dioxides as Antimycobacterial Agents: Mechanistic Studies and Therapeutic Potential. Pharmaceuticals, 16(11), 1565. https://doi.org/10.3390/ph16111565